China’s Orthopedics Battle: Stryker Jumps In To Buy Trauson
This article was originally published in PharmAsia News
Executive Summary
China’s red hot orthopedics market sees another major deal, with Stryker offering to acquire Trauson Holdings for $764 million, a 45% premium over the firm’s last closing price.